Eikon Therapeutics, Inc. EIKN Income Statement
| Q1 '26 | ||
|---|---|---|
| $4.38M+38.6% | ||
| $70.05M+23.8% | ||
| $17.29M+16.9% | ||
| $87.34M+22.3% | ||
| $87.34M+22.3% | ||
| -$87.34M-22.3% | ||
| -$82.96M-21.6% | ||
| -$2.46+90.9% | ||
| -$2.46+90.9% | ||
| 33.7M+1,116% | ||
| 33.7M+1,116% | ||
| —— | ||
| $4.38M+38.6% | ||
| -$1K+95.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Eikon Therapeutics, Inc. 's income statement data come from?
- Every line is extracted from Eikon Therapeutics, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.